Citius Pharmaceuticals Inc. (CTXR) Declined -5.94% or -0.08 To Price $1.34 On Thursday

Citius Pharmaceuticals Inc. (CTXR) declined -5.94% or -0.08 to $1.34. It is close to 79681 shares traded, which is 54.5% compare to the average total volume 146194. The market cap of CTXR is $24.91 million. The year to date change is 26.46%. The 52 week price range is from $0.86 to $3.38. Price of CTXR have changed 17.21% during last week. It have changed 48.96% over last month, 33.71% over last 3 months, 0.00% over last 6 months and -55.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTXR is 1.11. It is -17.16% below current price. The 200-day Moving Averages for CTXR is 1.65. It is 23.13% above current price. The 52-week High is 3.38. It is 152.24% from the current price. The 52-week Low is 0.86. It is -35.82% from current price.

There are some statistics of CTXR. It is has market cap $24.91 million. The share outstanding is 18.52 million. The average volume is 146194. The percent of top 15 Institution holding is 5.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTXR is -52.62%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTXR is -46.56%.


Share this post